Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| SILDENAFIL | VEGA 50 mg film-coated tablet | 50 | 43.7 | Details | |
| CLARITHROMYCIN | KLARE 500 mg film-coated tablet | 500 | 46.05 | Details | |
| CANDESARTAN CILEXETIL | CANDAN 16 mg tablet | 16 | 45.85 | Details | |
| CANDESARTAN CILEXETIL,HYDROCHLOROTHIAZIDE | CANDAN PLUS 16/12.5 mg tablet | 16,12.5 | 51.35 | Details | |
| AZILSARTAN MEDOXOMIL | EDARBI 40 mg tablet | 40 | 65.2 | Details | |
| AZILSARTAN MEDOXOMIL | EDARBI 80 mg tablet | 80 | 97.85 | Details | |
| TADALAFIL | SNAFI 20MG TAB | 20 | 133.4 | Details | |
| HUMAN COAGULATION FACTOR VIII | ADVATE 1000 IU | 1000 | 2504.7 | Details | |
| ASCORBIC ACID | REDOXON EFFERVESCENT TAB | 1 | 14.15 | Details | |
| ACYCLOVIR | SAVIR 5% cream | 5 | 38.00 | Details | |
| CILASTATIN,IMIPENEM | ZAYNAM powder for solution for infusion | 500,500 | 47.85 | Details | |
| PROPRANOLOL | PROTENSE 40 mg/5 ml oral solution | 8 | 110 | Details | |
| MEROPENEM | ARCHIFAR 500 mg powder for solution for injection or infusion | 500 | 382.60 | Details | |
| MEROPENEM | ARCHIFAR 1000 mg powder for solution for injection or infusion | 1000 | 719.15 | Details | |
| DIGOXIN | LANOXIN 0.25MG/ML INJ | 0.25 | 13.2 | Details | |
| EZETIMIBE | EZECHOL 10 mg tablet | 10 | 131.65 | Details | |
| ESCITALOPRAM | SETAPRO 20 mg film-coated tablet | 20 | 93.25 | Details | |
| ESCITALOPRAM | SETAPRO 10 mg film-coated tablet | 10 | 46.6 | Details | |
| ROPINIROLE | REQUIP PD 24HOUR 2 mg prolonged release tablet | 2 | 32.75 | Details | |
| ROPINIROLE | REQUIP PD 24HOUR 4 mg prolonged release tablet | 4 | 68.7 | Details |
6.93% of users said yes from 101 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.